1. Home
  2. VANI vs KPLT Comparison

VANI vs KPLT Comparison

Compare VANI & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • KPLT
  • Stock Information
  • Founded
  • VANI 1998
  • KPLT 2012
  • Country
  • VANI United States
  • KPLT United States
  • Employees
  • VANI N/A
  • KPLT N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KPLT Diversified Commercial Services
  • Sector
  • VANI Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • VANI Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • VANI 81.2M
  • KPLT 79.1M
  • IPO Year
  • VANI 2014
  • KPLT N/A
  • Fundamental
  • Price
  • VANI $1.47
  • KPLT $11.64
  • Analyst Decision
  • VANI Strong Buy
  • KPLT Hold
  • Analyst Count
  • VANI 1
  • KPLT 1
  • Target Price
  • VANI $4.00
  • KPLT $10.00
  • AVG Volume (30 Days)
  • VANI 154.3K
  • KPLT 102.3K
  • Earning Date
  • VANI 11-12-2025
  • KPLT 11-05-2025
  • Dividend Yield
  • VANI N/A
  • KPLT N/A
  • EPS Growth
  • VANI N/A
  • KPLT N/A
  • EPS
  • VANI N/A
  • KPLT N/A
  • Revenue
  • VANI N/A
  • KPLT $267,101,999.00
  • Revenue This Year
  • VANI N/A
  • KPLT $22.88
  • Revenue Next Year
  • VANI N/A
  • KPLT $10.98
  • P/E Ratio
  • VANI N/A
  • KPLT N/A
  • Revenue Growth
  • VANI N/A
  • KPLT 13.04
  • 52 Week Low
  • VANI $0.91
  • KPLT $5.08
  • 52 Week High
  • VANI $1.80
  • KPLT $24.34
  • Technical
  • Relative Strength Index (RSI)
  • VANI 56.91
  • KPLT 36.26
  • Support Level
  • VANI $1.36
  • KPLT $13.18
  • Resistance Level
  • VANI $1.45
  • KPLT $16.07
  • Average True Range (ATR)
  • VANI 0.07
  • KPLT 1.71
  • MACD
  • VANI -0.01
  • KPLT -0.31
  • Stochastic Oscillator
  • VANI 68.00
  • KPLT 9.93

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: